期刊文献+

HPLC-MS测定大鼠体内白杨素及其药代动力学 被引量:1

Determination of Chrysin in Rat Plasma by HPLC-MS and Related Pharmacokinetics Evaluation
原文传递
导出
摘要 目的建立HPLC-MS的方法测定大鼠血浆中白杨素含量。方法以柚皮素为内标;采用Waters Xtera C18色谱柱(150 mm×4.6 mm,5μm)分离,柱温设定为30℃;梯度洗脱:A相为乙腈,B相为0.05%甲酸;流速为0.8 ml·min-1,使用分流器将0.2 ml·min-1的洗脱液注入离子源;选择离子监测检测(SIM):白杨素m/z 255[M+H]+,内标柚皮素m/z 273[M+H]+。结果本研究所采用的方法检测限为1.5 ng·ml-1,定量限为4.0 ng·ml-1,且精密度、稳定性及回收率满足测定要求,并成功用于白杨素在大鼠体内的药动学评价。结论本研究建立了快速、准确的HPLC-MS法用于测定大鼠血浆中的白杨素含量,并成功拟合其药动学参数,白杨素在大鼠体内的药动学特性符合二室开放模型含量。 Objective To establish an HPLC-MS method to analyze the concentration of chrysin in rat plas- ma. Methods Naringenin was used as the internal standard. The separations was performed on a Waters Xtera C18 column (150 mm ×4.6 ram,5 μm). The column temperature was set at 30 ℃ ;the mobile phase was composed of acetonitrile (A) and 0.05 % formic acid solution. A linear gradient elution was used, and the flow rate was 0.8 ml · min-1.0.2 ml·min-1 elution buffer was transferred into the ion source by a solvent splitter,the ion monitor mode was chosen and the selected ions were m/z 255 [ M + H ] +for chrysin and m/z 273 [ M + H ] + for naringenin. Re- sults The limit of detection (LOD) and limit of quantitation (LOQ) were 1.5 and 4.0 ng·m1-1 respectively,with satisfactory precision, stability and recovery. This method was also applied to evaluate the Pharmacokinetics profile of chrysin. Conclusion A quick and accurate HPLC-MS method has been established to analyze the concentration of chrysin in rat plasma. Pharmacokinetics parameters are estimated accurately, and the data are fitted to a two-com- partment model with first-order absorption.
出处 《解放军药学学报》 CAS 2014年第1期37-39,51,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 白杨素 药动学 HPLC—MS chrysin pharmacokinetics HPLC-MS
  • 相关文献

参考文献3

二级参考文献44

  • 1诸敏,姚彤炜,曾苏.银杏黄酮的体外II相代谢及其临床应用[J].药学学报,2003,38(12):938-941. 被引量:3
  • 2汪涛,王建新,韩丽妹.银杏内酯B及银杏内酯提取物大鼠体内药动学比较[J].中国临床药理学与治疗学,2008,13(12):1411-1415. 被引量:6
  • 3王俊,任飞亮,裴元英.银杏总黄酮苷在大鼠体内的肠吸收动力学特征[J].中国临床药学杂志,2005,14(2):91-94. 被引量:11
  • 4Kloss P, Jaggy H. Verfahren zur gewinnung einesvasoaktiven Arzneimittel aus den. Blatten von Ginkgobiloba und Arzneiparapate [P]. DE: 2117429, 1972.
  • 5Maclennan K M, Darlington C L, Smith P F, et al. TheCNS effects of Ginkgo biloba extracts and ginkgolide B[J]. Prog Neurobiol, 2002,67(3): 235-257.
  • 6Pietta P Q Gardana C, Mauri R, et al. Identification ofGinkgo biloba flavonol metabolites after oraladministration to humans [J]. J Chromatogr B BiomedAppl, 1997,693(1): 249-255.
  • 7Wang F M, Yao T W, Zeng S,et al. Determination ofquercetin and kaempferol in human urine after orallyadministered tablet of Ginkgo biloba extract by HPLC [J].Pharm Biomed Anal, 2003,33(2): 317-321.
  • 8Zhao Y, Li W, Bao Y, et al. A sensitive method for thedetection and quantification of Ginkgo flavonols fromplasma [J]. Mass Spectrom, 2007,21(6): 971-981.
  • 9鄂蕴娟,袁立夫,尤献民,等.银杏总黄酮胃肠吸收动力学研究[J].中华中医药刊,2009, 27(2): 320-321.
  • 10Li L, Zhao Y S, Du F F, et al. Intestinal absorption andpresystemic elimination of various chemical constituentspresent in GBE50 extract, a standardized extract ofGinkgo biloba leaves [J]. Curr Drug Metab, 2012, 13(5):494-509.

共引文献126

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部